[의학신문·일간보사=김영주 기자]Handok (CEO Kim Young-jin, Paik Jin-ki) and start-up Welt (CEO Kang Seong-ji) are working on the development of digital therapeutics. On the 22nd, Handok made a stake investment worth 3 billion won in Welt and signed a strategic partnership to jointly develop a digital treatment for alcoholism and insomnia. Financial investors (FIs) in related fields also participated in this investment, and a total investment of 6 billion won was made.
 |
| Handok Chairman Kim Young-jin (left) and Welt CEO Kang Seong-ji are taking commemorative photos after signing a partnership between the two companies. |
As a result, Handok expanded its R&D area to include new biopharmaceuticals and medical devices as well as digital therapeutics. Handok plans to strengthen its capabilities in digital treatment research, development, and commercialization through Welt, and to jointly develop digital treatments for alcoholism and insomnia.
Handok secures exclusive sales rights in the domestic market for these two treatments, and has the right to first review the domestic joint development and commercialization of digital treatments developed or planned by Welt.
Welt is a startup that spun off from Samsung Electronics in 2016, cooperating with a number of government agencies, and is active as the first member of Asia to join the global digital therapy industry association’DTA (Digital Therapeutics Alliance)’.
Handok Chairman Kim Young-jin said, “I am very happy to cooperate with Welt, a leader in the field of digital therapeutics, amid the rapid growth of the digital healthcare market. “This will accelerate the development of innovative digital therapeutics.”
Reporter Kim Young-joo [email protected]
<저작권자 © 의학신문, 무단 전재 및 재배포 금지>